<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-134598</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Illness due the Ebola virus: epidemiology and clinical manifestations within the context of an international public health emergency</dc:title>
<dc:description xml:lang="en">Introduction. The epidemic caused by the Ebola virus in western Africa affects Guinea, Liberia, Sierra Leone, Nigeria, Mali and Senegal, and is the most serious to occur since the existence of this filovirus, which causes haemorrhagic fever, wasfirst reported. This article reviews the epidemiological characteristics and clinical manifestations associated with the disease due to the Ebola virus. Development. Until February 23, 2015 there have been 23,729 cases of Ebola, with a mortality rate of 40.1%. In the current epidemic, there are three ways the virus can be transmitted to human beings: contact with fluids and secretions from subjects already diagnosed with the disease, contact with dead bodies during burial ceremonies, and infection of relatives and healthcare personnel from as-yet undiagnosed patients. Ebola is the cause of a serious disease in humans. Following a period of incubation that can vary in length (2-21 days), a syndrome involving fever, headache, aching muscles, sore joints, vomiting and diarrhoea begins. The advanced phase is accompanied by haemorrhages, multiple organ failure, hypotension and shock. The incidence of neurological manifestations is unknown, but brain haemorrhages and post-infectious syndromes have been reported in other viral haemorrhagic fevers. Support care is vital. No proven effective treatment exists, although several patients have been treated with a cocktail of monoclonal antibodies (ZMapp). Conclusions. Early identification and diagnosis of suspected cases, isolation of sick patients and protective measures among healthcare staff are fundamental in the control of this epidemic (AU)</dc:description>
<dc:creator>Carod Artal, Francisco J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La epidemia causada por el virus del Ébola en África occidental afecta a Guinea, Liberia, Sierra Leona, Nigeria, Mali y Senegal, y es la más grave desde que se tiene noticia de este filovirus causante de fiebre hemorrágica. En este artículo se revisan las características epidemiológicas y las manifestaciones clínicas asociadas a la enfermedad por el virus del Ébola. Desarrollo. Hasta el 23 de febrero de 2015 se habían contabilizado 23.729 casos de ébola, con un 40,1% de mortalidad. En la actual epidemia, el virus se transmite al ser humano por tres vías: contacto con fluidos y secreciones de sujetos enfermos ya diagnosticados, contacto con cadáveres durante las ceremonias de enterramiento, y contagio a familiares y personal sanitario por enfermos sin diagnosticar. El Ébola causa una enfermedad grave en humanos. Tras un período de incubación variable (2-21 días), se inicia un síndrome febril, cefalea, mialgias, artralgias, vómitos y diarrea. La fase avanzada cursa con hemorragias, fracaso de múltiples órganos, hipotensión y choque. Se desconoce la incidencia de manifestaciones neurológicas, aunque se han descrito hemorragias cerebrales y síndromes postinfecciosos en otras fiebres hemorrágicas virales. Los cuidados de soporte son vitales. No existe un tratamiento efectivo demostrado, aunque varios pacientes han sido tratados con un cóctel de anticuerpos monoclonales (ZMapp). Conclusiones. La identificación y diagnóstico precoz de casos sospechosos, el aislamiento de sujetos enfermos y las medidas de protección en el personal sanitario son fundamentales para contener esta epidemia (AU)</dc:description>
<dc:source>Rev Neurol;60(6): 267-277, 16 mar., 2015. tab</dc:source>
<dc:identifier>ibc-134598</dc:identifier>
<dc:title xml:lang="es">Enfermedad por el virus del Ébola: epidemiología y manifestaciones clínicas en un contexto de emergencia de salud pública internacional</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d6412^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1850^s22044</dc:subject>
<dc:subject>^d32733^s32386</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d359^s22028</dc:subject>
<dc:subject>^d28455^s22018</dc:subject>
<dc:subject>^d6412^s32386</dc:subject>
<dc:subject>^d32733^s22062</dc:subject>
<dc:subject>^d27966^s22002</dc:subject>
<dc:subject>^d27966^s22045</dc:subject>
<dc:subject>^d27966^s22054</dc:subject>
<dc:subject>^d32733^s22044</dc:subject>
<dc:subject>^d32733^s22054</dc:subject>
<dc:subject>^d28455^s22041</dc:subject>
<dc:subject>^d27966^s22082</dc:subject>
<dc:subject>^d32733^s22069</dc:subject>
<dc:subject>^d359^s22080</dc:subject>
<dc:subject>^d1850^s32386</dc:subject>
<dc:subject>^d28455^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201503</dc:date>
</metadata>
</record>
</ibecs-document>
